European Archives - Page 1466 of 1489 - European Medical Journal

Antiphospholipid Syndrome Novel Therapies

Antiphospholipid syndrome (APS) is an autoimmune disease characterised by arterial and/or venous thrombosis, recurrent pregnancy loss, and persistently…

EMJ Rheumatology 2014

It is with great anticipation that I unveil to you our inaugural edition of the European Medical Journal – Rheumatology, which includes a review of…

Diagnostic Challenges in Thrombotic Microangiopathies

The Alexion Satellite Symposium provided an introduction to thrombotic microangiopathies (TMA) by Prof Dirk Kuypers, who described atypical haemolytic…

Bringing the Benefits of High-Dose Haemodialysis to the Home with a Novel Haemodialysis System

Haemodialysis (HD) is a haemodynamically traumatic practice that is known to cause ischaemic insult to a variety of organs. Reductions in perfusion…

Pain in Autosomal Dominant Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder affecting 1 in 1,000 people and is responsible for 10% of cases of…

Autosomal Dominant Polycystic Kidney Disease: Review and Management Update

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited nephropathy. Initially, it is characterised by the growth of renal…

Chronic Kidney Disease – Where Next? Predicting Outcomes and Planning Care Pathways

With the introduction of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative chronic kidney disease (CKD) guidelines, CKD has been…

No Added Mortality Benefit From Current Approaches to Renal Replacement Therapy in ICU Patients

Hospital-acquired acute kidney injury (AKI), a common and harmful renal disorder, is an independent risk factor for short-term and long-term mortality…

The Multidisciplinary Approach to Renal Denervation: Current Evidences and Open Questions

Renal denervation (RD) is a new clinical procedure which aims to treat resistant hypertensive patients. As with every new technology introduced into the…

Chronic Renal Allograft Dysfunction Antibody-Mediated: An Update

This paper reviews the most important studies on chronic antibody-mediated rejection (cABMR), which is an important cause of late graft dysfunction after…